e-learning
resources
Vienna 2003
Monday 29.09.2003
Lung cancer surgery: prognostic factors
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung cancer surgery and prognostic fators: c-erb-2, Ki-67 and β-Hcg
I. F. Toro, K. Metze, R. K. Mussi, J. C. Seabra, A. Garcia, L. Zambom (Campinas, Brazil)
Source:
Annual Congress 2003 - Lung cancer surgery: prognostic factors
Session:
Lung cancer surgery: prognostic factors
Session type:
Oral Presentation
Number:
1442
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. F. Toro, K. Metze, R. K. Mussi, J. C. Seabra, A. Garcia, L. Zambom (Campinas, Brazil). Lung cancer surgery and prognostic fators: c-erb-2, Ki-67 and β-Hcg. Eur Respir J 2003; 22: Suppl. 45, 1442
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Prognostic significance of p53 and bcl-2 abnormalities in operable non-small cell lung cancer
Source: Eur Respir J 2001; 17: 660-666
Year: 2001
The role of HER-2/neu, p53, Bcl-2 and Ki-67 in patients with lung cancer
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019
Prognostic significance of p53 and Ki-67 expression in Patients with Resected Lung squamous cell carcinoma
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications
Source: Eur Respir J 2009; 33: 127-133
Year: 2009
Immunohistochemical expression of nuclear factor kappa-B/p65 and cyclooxygenase-2 in non-small cell lung cancer patients: Prognostic value and impact on survival
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Correlation between the simultaneus expression of HER2 and PTEN and the risk of development of metastasis in NSCLC
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Prognostic significance of S-100 immmunostaining in non-small cell lung cancer (NSCLC)
Source: Annual Congress 2004 - Prognostic factors
Year: 2004
Neutrophil/lymphocyte ratio as a prognostic marker for curative-intent surgery in non-small cell lung cancer
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015
BAX and p16INK4A are independent positive prognostic markers for advanced tumour stage of nonsmall cell lung cancer
Source: Eur Respir J 2002; 19: 134-140
Year: 2002
Co-expression of S100A14 and S100A16 is a predictive marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinomas
Source: International Congress 2016 – Therapeutic trials in lung cancer
Year: 2016
Tumor laterality influences the prognostic impact of Bcl-2 expression in curatively resected NSCLC patients
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Prognostic significance of the expressions of Axl and/or Gas6 in patients with completely resected lung adenocarcinoma
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer
Source: Eur Respir J 2004; 23: 14-19
Year: 2004
beta-F1-ATPase expression as a prognostic factor for resected non-small cell lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Differences in expression and prognostic values of p16(ink) and VEGF in squamous and adenocarcinoma of the lung
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Prognostic significance of Nestin in resected non-small cell lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Prognostic significance of three tumor markers (CA125, CEA, and TPA) in lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 73s
Year: 2002
Clinical significance of serum survivin, MGB-1 and Pref-1 levels during chemotherapy of lung cancer
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
Bcl-2 as a prognostic factor for survival in small-cell lung cancer
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
Expression of Fhit protein in non-small cell lung cancer (NSCLC) and its correlation with Ki-67, a proliferative marker
Source: Eur Respir J 2002; 20: Suppl. 38, 230s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept